Transposagen Wins Prestigious Tibbetts Award for Development of Genome Engineering Technology

Lexington, KY, June 16, 2015 (GLOBE NEWSWIRE)

Transposagen Biopharmaceuticals, Inc. (“Transposagen”), a privately-held biotechnology company, has accepted the highly prestigious 2015 Tibbetts Award during a White House ceremony in Washington, D.C. The U.S Small Business Administration (SBA) recognized Transposagen with the award for having leveraged Small Business Innovation Research grants from the National Institutes of Health in a way that has generated measurable value to the firm and to the nation.

Read More